These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24923570)

  • 1. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
    Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
    Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort.
    Babić Leko M; Willumsen N; Nikolac Perković M; Klepac N; Borovečki F; Hof PR; Sonicki Z; Pivac N; de Silva R; Šimić G
    Brain Behav; 2018 Nov; 8(11):e01128. PubMed ID: 30329219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
    Mukherjee O; Kauwe JS; Mayo K; Morris JC; Goate AM
    BMC Genet; 2007 Jan; 8():3. PubMed ID: 17266761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
    Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Eisele T; Bäuml J; Förstl H; Kurz A; Riemenschneider M
    Mol Psychiatry; 2007 May; 12(5):510-7. PubMed ID: 17179995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
    Das G; Misra AK; Das SK; Ray K; Ray J
    Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.
    Zhang CC; Zhu JX; Wan Y; Tan L; Wang HF; Yu JT; Tan L
    Oncotarget; 2017 Jul; 8(27):44994-45007. PubMed ID: 28402959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An association study of common variation at the MAPT locus with late-onset Alzheimer's disease.
    Abraham R; Sims R; Carroll L; Hollingworth P; O'Donovan MC; Williams J; Owen MJ
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1152-5. PubMed ID: 19308965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
    Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
    Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
    Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
    Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
    Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.
    Fung HC; Xiromerisiou G; Gibbs JR; Wu YR; Eerola J; Gourbali V; Hellström O; Chen CM; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Hardy J; Singleton AB
    Neurodegener Dis; 2006; 3(6):327-33. PubMed ID: 17192721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
    Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
    Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.
    Conrad C; Vianna C; Schultz C; Thal DR; Ghebremedhin E; Lenz J; Braak H; Davies P
    J Neurochem; 2004 Apr; 89(1):179-88. PubMed ID: 15030402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic evidence that vascular dementia is related to Alzheimer's disease: genetic association between tau polymorphism and vascular dementia in the Chinese population.
    Ning M; Zhang Z; Chen Z; Zhao T; Zhang D; Zhou D; Li W; Liu Y; Yang Y; Li S; He L
    Age Ageing; 2011 Jan; 40(1):125-8. PubMed ID: 21044986
    [No Abstract]   [Full Text] [Related]  

  • 17. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
    J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
    Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
    Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.
    Strickland SL; Reddy JS; Allen M; N'songo A; Burgess JD; Corda MM; Ballard T; Wang X; Carrasquillo MM; Biernacka JM; Jenkins GD; Mukherjee S; Boehme K; Crane P; Kauwe JS; Ertekin-Taner N;
    Alzheimers Dement; 2020 Jul; 16(7):983-1002. PubMed ID: 32400971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
    Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
    Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.